Cargando…
Pulmonary vasculopathy in explanted lungs from patients with interstitial lung disease undergoing lung transplantation
BACKGROUND: Pulmonary hypertension (PH) causes increased morbidity and mortality in patients with interstitial lung diseases (ILD). Classification schemes, while well-characterised for the vasculopathy of idiopathic PH, have been applied, unchallenged, to ILD-related PH. We evaluated pulmonary arter...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7359183/ https://www.ncbi.nlm.nih.gov/pubmed/32661103 http://dx.doi.org/10.1136/bmjresp-2019-000532 |
_version_ | 1783558996325564416 |
---|---|
author | Dotan, Yaniv Stewart, Jeffrey Gangemi, Andrew Wang, He Aneja, Amandeep Chakraborty, Baidarbhi Dass, Chandra Zhao, Huaqing Marchetti, Nathaniel D'Alonzo, Gilbert Cordova, Francis C Criner, Gerard Mamary, Albert James |
author_facet | Dotan, Yaniv Stewart, Jeffrey Gangemi, Andrew Wang, He Aneja, Amandeep Chakraborty, Baidarbhi Dass, Chandra Zhao, Huaqing Marchetti, Nathaniel D'Alonzo, Gilbert Cordova, Francis C Criner, Gerard Mamary, Albert James |
author_sort | Dotan, Yaniv |
collection | PubMed |
description | BACKGROUND: Pulmonary hypertension (PH) causes increased morbidity and mortality in patients with interstitial lung diseases (ILD). Classification schemes, while well-characterised for the vasculopathy of idiopathic PH, have been applied, unchallenged, to ILD-related PH. We evaluated pulmonary arterial histopathology in explanted human lung tissue from patients who were transplanted for advanced fibrotic ILD. METHODS: Lung explants from 38 adult patients who underwent lung transplantation were included. Patients were divided into three groups: none, mild/moderate and severe PH by mean pulmonary artery pressure (mPAP) measured at pre lung transplantation right heart catheterisation (RHC). Grading of pulmonary vasculopathy according to Heath and Edwards scheme, and prelung transplantation evaluation data were compared between the groups. RESULTS: 38 patients with fibrotic ILDs were included, the majority (21) with idiopathic pulmonary fibrosis. Of the 38 patients, 18 had severe PH, 13 had mild/moderate PH and 7 had no PH by RHC. 16 of 38 patients had severe pulmonary arterial vasculopathy including vascular occlusion with intimal fibrosis and/or plexiform lesions. There were no correlations between mPAP and lung diffusion with the severity of pulmonary arterial pathological grade (Spearman’s rho=0.14, p=0.34, rho=0.11, p=0.49, respectively). CONCLUSIONS: Patients with end stage ILD had severe pulmonary arterial vasculopathy in their explanted lungs irrespective of the presence and/or severity of PH as measured by RHC. These findings suggest that advanced pulmonary arterial vasculopathy is common in patients with advanced fibrotic ILD and may develop prior to the clinical detection of PH by RHC. |
format | Online Article Text |
id | pubmed-7359183 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-73591832020-07-16 Pulmonary vasculopathy in explanted lungs from patients with interstitial lung disease undergoing lung transplantation Dotan, Yaniv Stewart, Jeffrey Gangemi, Andrew Wang, He Aneja, Amandeep Chakraborty, Baidarbhi Dass, Chandra Zhao, Huaqing Marchetti, Nathaniel D'Alonzo, Gilbert Cordova, Francis C Criner, Gerard Mamary, Albert James BMJ Open Respir Res Pulmonary Vasculature BACKGROUND: Pulmonary hypertension (PH) causes increased morbidity and mortality in patients with interstitial lung diseases (ILD). Classification schemes, while well-characterised for the vasculopathy of idiopathic PH, have been applied, unchallenged, to ILD-related PH. We evaluated pulmonary arterial histopathology in explanted human lung tissue from patients who were transplanted for advanced fibrotic ILD. METHODS: Lung explants from 38 adult patients who underwent lung transplantation were included. Patients were divided into three groups: none, mild/moderate and severe PH by mean pulmonary artery pressure (mPAP) measured at pre lung transplantation right heart catheterisation (RHC). Grading of pulmonary vasculopathy according to Heath and Edwards scheme, and prelung transplantation evaluation data were compared between the groups. RESULTS: 38 patients with fibrotic ILDs were included, the majority (21) with idiopathic pulmonary fibrosis. Of the 38 patients, 18 had severe PH, 13 had mild/moderate PH and 7 had no PH by RHC. 16 of 38 patients had severe pulmonary arterial vasculopathy including vascular occlusion with intimal fibrosis and/or plexiform lesions. There were no correlations between mPAP and lung diffusion with the severity of pulmonary arterial pathological grade (Spearman’s rho=0.14, p=0.34, rho=0.11, p=0.49, respectively). CONCLUSIONS: Patients with end stage ILD had severe pulmonary arterial vasculopathy in their explanted lungs irrespective of the presence and/or severity of PH as measured by RHC. These findings suggest that advanced pulmonary arterial vasculopathy is common in patients with advanced fibrotic ILD and may develop prior to the clinical detection of PH by RHC. BMJ Publishing Group 2020-07-12 /pmc/articles/PMC7359183/ /pubmed/32661103 http://dx.doi.org/10.1136/bmjresp-2019-000532 Text en © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/. |
spellingShingle | Pulmonary Vasculature Dotan, Yaniv Stewart, Jeffrey Gangemi, Andrew Wang, He Aneja, Amandeep Chakraborty, Baidarbhi Dass, Chandra Zhao, Huaqing Marchetti, Nathaniel D'Alonzo, Gilbert Cordova, Francis C Criner, Gerard Mamary, Albert James Pulmonary vasculopathy in explanted lungs from patients with interstitial lung disease undergoing lung transplantation |
title | Pulmonary vasculopathy in explanted lungs from patients with interstitial lung disease undergoing lung transplantation |
title_full | Pulmonary vasculopathy in explanted lungs from patients with interstitial lung disease undergoing lung transplantation |
title_fullStr | Pulmonary vasculopathy in explanted lungs from patients with interstitial lung disease undergoing lung transplantation |
title_full_unstemmed | Pulmonary vasculopathy in explanted lungs from patients with interstitial lung disease undergoing lung transplantation |
title_short | Pulmonary vasculopathy in explanted lungs from patients with interstitial lung disease undergoing lung transplantation |
title_sort | pulmonary vasculopathy in explanted lungs from patients with interstitial lung disease undergoing lung transplantation |
topic | Pulmonary Vasculature |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7359183/ https://www.ncbi.nlm.nih.gov/pubmed/32661103 http://dx.doi.org/10.1136/bmjresp-2019-000532 |
work_keys_str_mv | AT dotanyaniv pulmonaryvasculopathyinexplantedlungsfrompatientswithinterstitiallungdiseaseundergoinglungtransplantation AT stewartjeffrey pulmonaryvasculopathyinexplantedlungsfrompatientswithinterstitiallungdiseaseundergoinglungtransplantation AT gangemiandrew pulmonaryvasculopathyinexplantedlungsfrompatientswithinterstitiallungdiseaseundergoinglungtransplantation AT wanghe pulmonaryvasculopathyinexplantedlungsfrompatientswithinterstitiallungdiseaseundergoinglungtransplantation AT anejaamandeep pulmonaryvasculopathyinexplantedlungsfrompatientswithinterstitiallungdiseaseundergoinglungtransplantation AT chakrabortybaidarbhi pulmonaryvasculopathyinexplantedlungsfrompatientswithinterstitiallungdiseaseundergoinglungtransplantation AT dasschandra pulmonaryvasculopathyinexplantedlungsfrompatientswithinterstitiallungdiseaseundergoinglungtransplantation AT zhaohuaqing pulmonaryvasculopathyinexplantedlungsfrompatientswithinterstitiallungdiseaseundergoinglungtransplantation AT marchettinathaniel pulmonaryvasculopathyinexplantedlungsfrompatientswithinterstitiallungdiseaseundergoinglungtransplantation AT dalonzogilbert pulmonaryvasculopathyinexplantedlungsfrompatientswithinterstitiallungdiseaseundergoinglungtransplantation AT cordovafrancisc pulmonaryvasculopathyinexplantedlungsfrompatientswithinterstitiallungdiseaseundergoinglungtransplantation AT crinergerard pulmonaryvasculopathyinexplantedlungsfrompatientswithinterstitiallungdiseaseundergoinglungtransplantation AT mamaryalbertjames pulmonaryvasculopathyinexplantedlungsfrompatientswithinterstitiallungdiseaseundergoinglungtransplantation |